Mount Vernon Associates Inc Merck & Co., Inc. Transaction History

Mount Vernon Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$87.44 - $112.11 $8,744 - $11,211	-100 Reduced 4.22%	2,270 $252,000
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $41,745 - $47,320	-500 Reduced 17.42%	2,370 $216,000
Q4 2020 Jan 25, 2021	SELL	$71.77 - $79.65 $35,885 - $39,825	-500 Reduced 14.84%	2,870 $235,000
Q1 2020 Apr 23, 2020	SELL	$63.36 - $87.82 $6,336 - $8,782	-100 Reduced 2.88%	3,370 $259,000
Q2 2019 Jul 30, 2019	SELL	$69.84 - $81.59 $151,552 - $177,050	-2,170 Reduced 38.48%	3,470 $291,000
Q2 2019 Jul 25, 2019	BUY	$69.84 - $81.59 $151,552 - $177,050	2,170 Added 62.54%	5,640 $473,000
Q2 2018 Jul 27, 2018	BUY	$50.83 - $59.72 $176,380 - $207,228	3,470 New	3,470 $211,000
Q4 2017 Jan 24, 2018	SELL	$51.62 - $61.64 $179,121 - $213,890	-3,470 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$58.67 - $63.13 $203,584 - $219,061	3,470	3,470 $222,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Mount Vernon Associates Inc with notifications on news.